Heart failure care evaluation for adults at this clinic
Part of Heart & circulation clinical trials.
This study looks at how people with heart failure are evaluated and managed in the clinic. It mainly involves follow-up care and documenting your treatment plans to improve how care is delivered.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Be seen in this clinic/unit for heart failure care at this hospital
- Be willing to sign the study consent form
- You must sign consent before joining (no exceptions noted)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how to better assess and manage risk in people hospitalized with heart failure or related serious heart problems. It may help by improving how clinicians monitor your condition over time and decide next steps.
This study welcomes people with heart failure (both sudden/worsening and long-term). It will check how heart failure care is managed, and it only moves forward if you choose to participate.
This study follows people with heart failure over time to record outcomes like illness course and death, and to understand how treatments affect results. If you have heart failure and can join regular check-ins, your information may help improve future care.
This study creates a registry of people with chronic heart failure to track their health over time. It may help researchers learn more about the condition and improve future care.
This study tests a new outpatient care approach for people with heart failure to help manage symptoms like shortness of breath and fluid buildup. You may be eligible if you are stable enough to attend visits and meet specific heart failure and lab/imaging criteria.
This is a hospital-based study that collects standardized information about adults with specific heart conditions—heart failure, coronary artery disease, or atrial fibrillation. It may help doctors and researchers better understand these diseases and improve future care.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.